retatrutide phase 3 trials Lilly's triple agonist delivers up to 71.2 lbs of weight loss Lilly's triple agonist achieves 16.8%

Further, clinical trials show that long-acting GLP-1 medicines decrease cardiovascular events in individuals with T2D or obesity

Aim for 2 to 3 liters of water daily

Finally, HumeCare's page describes an "exit strategy" phase once you reach your target - a personalized transition plan aimed at maintaining your results after you taper off medication, rather than assuming you'll stay on the program indefinitely

When considering what to eat on Mounjaro or other GLP-1 therapies, focus should shift toward smaller, nutrient-dense portions that prioritise lean proteins and high-fibre vegetables

Run by Invex Therapeutics, it will randomise 240 adult patients with newly diagnosed IIH with papilloedema to determine the efficacy and safety of Presendin, administered once weekly over 24 weeks

But what happens when you stop taking them